HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$0.54
Day range
$0.53 - $0.57
Year range
$0.31 - $4.85
Market cap
5.06M USD
Avg Volume
10.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.88M | 44.39% |
Operating expense | 11.43M | 960.60% |
Net income | -2.77M | 22.35% |
Net profit margin | -147.03 | 46.23% |
Earnings per share | — | — |
EBITDA | -2.78M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.31M | 23.08% |
Total assets | 7.45M | 33.15% |
Total liabilities | 4.57M | 106.00% |
Total equity | 2.88M | — |
Shares outstanding | 9.28M | — |
Price to book | 0.77 | — |
Return on assets | -130.82% | — |
Return on capital | -312.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.77M | 22.35% |
Cash from operations | -1.53M | -99.69% |
Cash from investing | 0.00 | — |
Cash from financing | 4.16M | 3,597.95% |
Net change in cash | 2.64M | 504.77% |
Free cash flow | -1.69M | -553.58% |
About
Founded
2003
Headquarters
Website
Employees
8
